Cargando…

A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite

An oligomannose patch around the V3 base of HIV-1 envelope glycoprotein (Env) is recognized by multiple classes of broadly neutralizing antibodies (bNAbs). Here, we investigated the bNAb response to the V3 glycan supersite in an HIV-1–infected Chinese donor by Env-specific single B cell sorting, str...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sonu, Ju, Bin, Shapero, Benjamin, Lin, Xiaohe, Ren, Li, Zhang, Lei, Li, Dan, Zhou, Zehua, Feng, Yi, Sou, Cindy, Mann, Colin J., Hao, Yanling, Sarkar, Anita, Hou, Jiali, Nunnally, Christian, Hong, Kunxue, Wang, Shuo, Ge, Xiangyang, Su, Bin, Landais, Elise, Sok, Devin, Zwick, Michael B., He, Linling, Zhu, Jiang, Wilson, Ian A., Shao, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494343/
https://www.ncbi.nlm.nih.gov/pubmed/32938661
http://dx.doi.org/10.1126/sciadv.abb1328
_version_ 1783582730398728192
author Kumar, Sonu
Ju, Bin
Shapero, Benjamin
Lin, Xiaohe
Ren, Li
Zhang, Lei
Li, Dan
Zhou, Zehua
Feng, Yi
Sou, Cindy
Mann, Colin J.
Hao, Yanling
Sarkar, Anita
Hou, Jiali
Nunnally, Christian
Hong, Kunxue
Wang, Shuo
Ge, Xiangyang
Su, Bin
Landais, Elise
Sok, Devin
Zwick, Michael B.
He, Linling
Zhu, Jiang
Wilson, Ian A.
Shao, Yiming
author_facet Kumar, Sonu
Ju, Bin
Shapero, Benjamin
Lin, Xiaohe
Ren, Li
Zhang, Lei
Li, Dan
Zhou, Zehua
Feng, Yi
Sou, Cindy
Mann, Colin J.
Hao, Yanling
Sarkar, Anita
Hou, Jiali
Nunnally, Christian
Hong, Kunxue
Wang, Shuo
Ge, Xiangyang
Su, Bin
Landais, Elise
Sok, Devin
Zwick, Michael B.
He, Linling
Zhu, Jiang
Wilson, Ian A.
Shao, Yiming
author_sort Kumar, Sonu
collection PubMed
description An oligomannose patch around the V3 base of HIV-1 envelope glycoprotein (Env) is recognized by multiple classes of broadly neutralizing antibodies (bNAbs). Here, we investigated the bNAb response to the V3 glycan supersite in an HIV-1–infected Chinese donor by Env-specific single B cell sorting, structural and functional studies, and longitudinal analysis of antibody and virus repertoires. Monoclonal antibodies 438-B11 and 438-D5 were isolated that potently neutralize HIV-1 with moderate breadth, are encoded by the V(H)1-69 germline gene, and have a disulfide-linked long HCDR3 loop. Crystal structures of Env-bound and unbound antibodies revealed heavy chain–mediated recognition of the glycan supersite with a unique angle of approach and a critical role of the intra-HCDR3 disulfide. The mechanism of viral escape was examined via single-genome amplification/sequencing and glycan mutations around the N332 supersite. Our findings further emphasize the V3 glycan supersite as a prominent target for Env-based vaccine design.
format Online
Article
Text
id pubmed-7494343
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-74943432020-09-23 A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite Kumar, Sonu Ju, Bin Shapero, Benjamin Lin, Xiaohe Ren, Li Zhang, Lei Li, Dan Zhou, Zehua Feng, Yi Sou, Cindy Mann, Colin J. Hao, Yanling Sarkar, Anita Hou, Jiali Nunnally, Christian Hong, Kunxue Wang, Shuo Ge, Xiangyang Su, Bin Landais, Elise Sok, Devin Zwick, Michael B. He, Linling Zhu, Jiang Wilson, Ian A. Shao, Yiming Sci Adv Research Articles An oligomannose patch around the V3 base of HIV-1 envelope glycoprotein (Env) is recognized by multiple classes of broadly neutralizing antibodies (bNAbs). Here, we investigated the bNAb response to the V3 glycan supersite in an HIV-1–infected Chinese donor by Env-specific single B cell sorting, structural and functional studies, and longitudinal analysis of antibody and virus repertoires. Monoclonal antibodies 438-B11 and 438-D5 were isolated that potently neutralize HIV-1 with moderate breadth, are encoded by the V(H)1-69 germline gene, and have a disulfide-linked long HCDR3 loop. Crystal structures of Env-bound and unbound antibodies revealed heavy chain–mediated recognition of the glycan supersite with a unique angle of approach and a critical role of the intra-HCDR3 disulfide. The mechanism of viral escape was examined via single-genome amplification/sequencing and glycan mutations around the N332 supersite. Our findings further emphasize the V3 glycan supersite as a prominent target for Env-based vaccine design. American Association for the Advancement of Science 2020-09-16 /pmc/articles/PMC7494343/ /pubmed/32938661 http://dx.doi.org/10.1126/sciadv.abb1328 Text en Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Kumar, Sonu
Ju, Bin
Shapero, Benjamin
Lin, Xiaohe
Ren, Li
Zhang, Lei
Li, Dan
Zhou, Zehua
Feng, Yi
Sou, Cindy
Mann, Colin J.
Hao, Yanling
Sarkar, Anita
Hou, Jiali
Nunnally, Christian
Hong, Kunxue
Wang, Shuo
Ge, Xiangyang
Su, Bin
Landais, Elise
Sok, Devin
Zwick, Michael B.
He, Linling
Zhu, Jiang
Wilson, Ian A.
Shao, Yiming
A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
title A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
title_full A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
title_fullStr A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
title_full_unstemmed A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
title_short A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
title_sort v(h)1-69 antibody lineage from an infected chinese donor potently neutralizes hiv-1 by targeting the v3 glycan supersite
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494343/
https://www.ncbi.nlm.nih.gov/pubmed/32938661
http://dx.doi.org/10.1126/sciadv.abb1328
work_keys_str_mv AT kumarsonu avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT jubin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT shaperobenjamin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT linxiaohe avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT renli avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zhanglei avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT lidan avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zhouzehua avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT fengyi avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT soucindy avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT manncolinj avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT haoyanling avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT sarkaranita avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT houjiali avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT nunnallychristian avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT hongkunxue avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT wangshuo avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT gexiangyang avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT subin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT landaiselise avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT sokdevin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zwickmichaelb avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT helinling avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zhujiang avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT wilsoniana avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT shaoyiming avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT kumarsonu vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT jubin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT shaperobenjamin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT linxiaohe vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT renli vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zhanglei vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT lidan vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zhouzehua vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT fengyi vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT soucindy vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT manncolinj vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT haoyanling vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT sarkaranita vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT houjiali vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT nunnallychristian vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT hongkunxue vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT wangshuo vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT gexiangyang vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT subin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT landaiselise vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT sokdevin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zwickmichaelb vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT helinling vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT zhujiang vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT wilsoniana vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite
AT shaoyiming vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite